Financial and demographic pressures in US require an understanding of the most efficient distribution of physicians to maximize population-level health benefits. Prior work has assumed a constant negative relationship between physician supply and mortality outcomes throughout the US and has not addressed regional variation.
FREE DAILY AND WEEKLY NEWSLETTERS OFFERED BY CONTENT OF INTEREST
Did you find this article relevant? Subscribe to UroToday-GUOncToday!
The fields of GU Oncology and Urology are advancing rapidly including new treatments, enrolling clinical trials, screening and surveillance recommendations along with updated guidelines. Join us as one of our subscribers who rely on UroToday as their must-read source for the latest news and data on drugs. Sign up today for blogs, video conversations, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.
In this ecological analysis, geographically weighted regression was used to identify spatially varying relationships between local urologist density and prostate cancer mortality at the county level. Data from 1,492 counties in 30 eastern and southern states from 2006-2010 were analyzed.
The ordinary least squares (OLS) regression found that, on average, increasing urologist density by 1 urologist per 100,000 people resulted in an expected decrease in prostate cancer mortality of -0. 499 deaths per 100,000 men (95% CI -0. 709 to -0. 289, p-value < 0. 001), or a 1. 5% decrease. Geographic weighted regression demonstrated that the addition of one urologist per 100,000 people in counties in the southern Mississippi River states of Arkansas, Mississippi, and Louisiana, as well as parts of Illinois, Indiana, and Wisconsin is associated with decrease of 0. 411 to 0. 916 in prostate cancer mortality per 100,000 men (1. 6-3. 6%). In contrast, the urologist density was not significantly associated with the prostate state mortality in the new England region.
The strength of association between urologist density and prostate cancer mortality varied regionally. Those areas with the highest potential for effects could be targeted for increasing the supply of urologists, as it associated with the largest predicted improvement in prostate cancer mortality.
PloS one. 2015 Jun 25*** epublish ***
Nengliang Yao, Steven M Foltz, Anobel Y Odisho, David C Wheeler
Department of Healthcare Policy and Research, Virginia Commonwealth University, Richmond, VA, United States of America. , Department of Healthcare Policy and Research, Virginia Commonwealth University, Richmond, VA, United States of America. , Department of Urology, Helen Diller Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, United States of America. , Department of Biostatistics, Virginia Commonwealth University, Richmond, VA, United States of America.